Trial intelligence / Profile preview

PEG vs PEG plus bisacodil for colonoscopy in IBD

NCT02248337Phase 4Completed

Sponsor
Luigi Sacco University Hospital
Start
Mar 2013
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bisacodyl, macrogol in inflammatory bowel disease (IBD), sponsored by Luigi Sacco University Hospital. Started Mar 2013; status: completed.

02

Drugs

bisacodylmacrogol
03

Conditions

inflammatory bowel disease (IBD)

Beyond the preview

Go deeper on NCT02248337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02248337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call